DEF 14A: Innventure Seeks Shareholder Approval for Dilutive Debentures

Innventure, Inc. is seeking stockholder approval for the potential issuance of common stock exceeding 20% to YA II PN, LTD. (Yorkville) under two convertible debenture agreements to fund working capital and operating expenses.

Summary

• A Special Meeting of Stockholders will be held virtually on Tuesday, December 2, 2025, at 2:00 p.m. Eastern Time.
• Stockholders are asked to approve the issuance of 20% or more of the company's common stock as of September 15, 2025, pursuant to the September 2025 Convertible Debentures with Yorkville (Proposal 1).
• Stockholders are also asked to approve the issuance of 20% or more of the company's common stock as of March 25, 2025, pursuant to the March 2025 Convertible Debentures with Yorkville (Proposal 2).
• A third proposal seeks approval for the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes for the Yorkville Proposals.
• The Board of Directors unanimously recommends voting FOR all three proposals.
• The purpose of these issuances is to fund working capital and operating expenses for Innventure LLC, AeroFlexx, LLC, Accelsius Holdings LLC, and Refinity Olefins, LLC (collectively, the Operating Companies).
• Failure to approve these proposals could trigger Amortization Events, requiring the company to make mandatory monthly cash prepayments, which would impair working capital.
• The potential issuance of shares under these debentures will dilute, and thereby reduce, each existing stockholder's proportionate ownership in the common stock.

Sentiment

Score: 3

Explanation: The filing indicates a critical need for capital to fund ongoing operations, secured through highly dilutive convertible debentures with unfavorable conversion terms (low floor prices relative to historical trading). While the funding itself is a positive for continuity, the significant potential for shareholder dilution and the consequences of non-approval (mandatory prepayments, further working capital impairment) suggest a challenging financial situation. The board's unanimous recommendation highlights the necessity of these proposals.

Positives

• Secured funding for working capital and operating expenses through convertible debentures, with $10.0 million already received from the September 2025 debentures and an additional $5.0 million expected.
• The March 2025 Convertible Debentures have already provided up to $30.0 million in funding, with $18.0 million outstanding.
• Stockholder approval will decrease the likelihood of Amortization Events, avoiding mandatory monthly cash prepayments and associated premiums (5% payment premium, 10% redemption premium) that would otherwise be triggered.
• The debentures include a floor price for conversion, providing a minimum conversion price (though still potentially low) for the company.

Negatives

• Significant potential for material dilution of existing stockholders' proportionate ownership if the proposals are approved and the debentures convert.
• The conversion prices for the debentures can be as low as $1.16 per share for the September 2025 debentures and $1.59 per share for the March 2025 debentures, which are substantially below the common stock price of $3.19 per share on the Record Date.
• Failure to approve the proposals would trigger mandatory monthly cash prepayments, which would impair working capital and the ability to fund operating expenses.
• The September 2025 Convertible Debentures bear an annual interest rate of 18.0% if an event of default occurs and remains uncured.

Risks

• Material dilution of current stockholders' proportionate ownership and voting power if the proposals are approved and the convertible debentures are fully converted.
• Financial strain and impairment of working capital if the proposals are not approved, leading to mandatory monthly cash prepayments under the debenture terms.
• Exposure to an 18.0% annual interest rate on the September 2025 Convertible Debentures if an event of default occurs.
• Inability to adequately fund working capital and operating expenses for the Operating Companies (Innventure LLC, AeroFlexx, LLC, Accelsius Holdings LLC, and Refinity Olefins, LLC) if the proposals are not approved.
• Stock price volatility could lead to more shares being issued upon conversion due to the variable conversion price tied to the volume-weighted average price (VWAP), exacerbating dilution.

Future Outlook

The company expects that stockholder approval of the proposals will enable it to continue funding working capital and operating expenses for its Operating Companies (Innventure LLC, AeroFlexx, LLC, Accelsius Holdings LLC, and Refinity Olefins, LLC). Approval is also anticipated to prevent the occurrence of Amortization Events, thereby avoiding mandatory monthly cash prepayments and associated financial strain.

Management Comments

• Our Board of Directors unanimously recommends that you vote FOR the issuance of 20% or more of the Company's issued and outstanding Common Stock as of September 15, 2025, pursuant to the September 2025 Convertible Debentures with Yorkville.
• Our Board of Directors unanimously recommends that you vote FOR the issuance of 20% or more of the Company's issued and outstanding Common Stock as of March 25, 2025, pursuant to the March 2025 Convertible Debentures with Yorkville.
• Our Board of Directors unanimously recommends that you vote FOR the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Yorkville Proposals.

Industry Context

The company's reliance on convertible debenture financing from a single entity (Yorkville) to fund working capital and operating expenses suggests it is either in a high-growth phase requiring substantial capital or facing challenges in securing less dilutive forms of financing. This is common for companies with early-stage or developing 'Operating Companies' like AeroFlexx, Accelsius, and Refinity Olefins, which may not yet be generating sufficient cash flow to support their operations. The need for shareholder approval to exceed Nasdaq's 20% issuance cap indicates the significant scale of this financing relative to the company's existing equity base.

Comparison to Industry Standards

• The company's need to seek shareholder approval for issuing shares exceeding 20% of its outstanding common stock at a price below the minimum price, or potentially resulting in a change of control, is in direct compliance with Nasdaq Listing Rules 5635(d) and 5635(b), which are standard regulatory requirements for publicly traded companies.
• The terms of the convertible debentures, including variable conversion prices tied to VWAP, floor prices, and high default interest rates (18.0%), are characteristic of financing arrangements often utilized by companies that may be perceived as higher risk or in need of flexible capital, similar to those seen in certain early-stage technology or development-focused companies.
• No specific comparable companies, projects, or results are mentioned in the filing to allow for a direct comparative assessment of the financing terms or operational performance against industry benchmarks.

Related Party Transactions

• The company has entered into Securities Purchase Agreements and Convertible Debenture agreements with YA II PN, LTD. (Yorkville), which are related party transactions given Yorkville's role as a significant financing partner and potential future shareholder.

Stakeholder Impact

• **Shareholders**: Face significant potential dilution of their ownership and voting power if the proposals are approved and the debentures convert. Non-approval could lead to financial instability and mandatory prepayments, negatively impacting share value.
• **Employees**: Continued funding of operating expenses, enabled by these debentures, helps ensure business continuity and job security.
• **Operating Companies (Innventure LLC, AeroFlexx, LLC, Accelsius Holdings LLC, Refinity Olefins, LLC)**: The funding is critical for their working capital and operating expenses, directly impacting their ability to operate and develop.
• **Yorkville**: As the debenture holder, Yorkville stands to convert debt into common stock, potentially at a discount, and benefits from protective clauses like high default interest rates and amortization events.

Next Steps

• Stockholders will vote on the proposals at the Special Meeting on December 2, 2025.
• The company will file a registration statement registering the resale of shares issuable upon conversion of the September 2025 Convertible Debentures.
• Yorkville will purchase an additional $5.0 million in September 2025 Convertible Debentures after the registration statement is filed and declared effective by the SEC.
• The company plans to announce preliminary voting results at the Special Meeting and publish final results in a Current Report on Form 8-K within four business days following the meeting.

Key Dates

Recommendation

The company is in a precarious financial position, evidenced by its reliance on highly dilutive convertible debentures with unfavorable conversion prices (potentially as low as $1.16 and $1.59, significantly below current and historical trading prices) to fund basic working capital and operating expenses. The need for shareholder approval to exceed Nasdaq's 20% issuance cap for two separate debenture agreements with the same entity (Yorkville) highlights the magnitude of the dilution. Failure to approve these proposals would trigger mandatory cash prepayments, further straining liquidity. While the board recommends approval to secure funding, the long-term implications of such significant dilution at low prices, coupled with the underlying need for this type of financing, suggest a challenging outlook for existing equity holders. This type of financing often precedes further capital raises or significant operational challenges, making the stock a high-risk investment with substantial downside potential from dilution.

Keywords

Innventure, Yorkville, Convertible Debentures, Stockholder Approval, Dilution, Nasdaq Listing Rules, Working Capital, Operating Expenses, Special Meeting, Proxy Statement, Common Stock, Preferred Stock, AeroFlexx, Accelsius, Refinity Olefins